Global Biotechnology Market to Reach $5 Trillion by 2032, Driven by Biopharmaceuticals, Gene Editing and Sustainable Innovation | Features Profiles of Danaher, Roche, Illumina, Merck, Thermo Fisher and More

Company Logo Target biopharma, gene editing and sustainable agriculture; leverage regional and competitive insights to uncover revenue opportunities and guide R&D investment Dublin…

AI 解读 · 本站研判

Elpiscience Biopharmaceuticals向港交所递表,这不是一条普通的IPO新闻,而是中国创新药行业资本寒冬中的一次关键试探。当市场对生物科技股从狂热转向理性,这家公司的估值逻辑将直接检验投资者对'中国创新'的信仰还剩多少。我的核心判断:短期情绪面利好,但长期价值取决于其核心管线能否在PD-1红海中杀出重围。别被'递表'二字迷惑,这背后是资本与科学的终极博弈。